Ojjaara: A New Oral Therapy to Treat Rare Blood Cancer

Ojjaara is an oral prescription medicine used to treat certain forms of myelofibrosis (a type of bone marrow cancer) in adults with anemia. Ojjaara is a brand-name product. It contains the active ingredient momelotinib, which belongs to the Janus kinase (JAK)...

Read more